Notes
1Abshire TC et al. Weekly polyethylene glycol conjugated L-asparaginase compared with biweekly dosing produces superior induction remission rates in childhood relapsed acute lymphoblastic leukemia: a Pediatric Oncology Group study. Blood. 2000, 96, 1709–15.
2Barredo JC et al. Isolated CNS Relapse of Acute Lymphoblastic Leukemia Treated With Intensive Systemic Chemotherapy and Delayed CNS Radiation: A Pediatric Oncology Group Study. J Clin Oncol. 2006, 24, 3142–9.
3Borowitz M et al. Minimal Residual Disease (MRD) in Childhood Acute Lymphoblastic Leukemia (ALL) in Relapse. A Children's Oncology Group (COG) Study (Meeting Abstract). Blood. 2004, 104, 324.
4Eapen M et al. Outcomes after HLA-matched sibling transplants or chemotherapy in children with B-precursor acute lymphoblastic leukemia in a second remission: a collaborative study of the Children's Oncology Group and the Center for International Blood and Marrow Transplant Research. Blood. 2006, 107, 4961–7.